Bo Han
22Patents
3h-index
45Co-inventors
59Inventor score
Filing activity: Sep 13, 2006 → Feb 28, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9266883B2 | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Chemistry; Metallurgy | 15 | Active |
| US9533988B2 | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Chemistry; Metallurgy | 12 | Active |
| US7541372B2 | Aryl-isoxazolo-4-yl-oxadiazole derivatives | Chemistry; Metallurgy | 7 | Active |
| US7470684B2 | Spiropiperidine derivatives as NK3 antagonists | Human Necessities | 3 | Active |
| US10130629B2 | Pharmaceutical combinations | Human Necessities | 3 | Active |
| US8779114B2 | siRNA conjugate and preparation method thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US9896449B2 | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US7388025B2 | 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives | Chemistry; Metallurgy | 2 | Active |
| US9802917B2 | Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide | Chemistry; Metallurgy | 2 | Active |
| US7851605B2 | Recombinant vaccine for preventing and treating porcine atrophic rhinitis | Human Necessities | 1 | Active |
| US8772472B2 | SiRNA conjugate and preparation method thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US7414061B2 | Aryl-isoxazol-4-yl-imidazole derivatives | Human Necessities | 1 | Active |
| US9211343B2 | siRNA conjugate and preparation method thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US10507201B2 | Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Human Necessities | 0 | Active |
| US7538132B2 | Isoxazolo derivatives | Chemistry; Metallurgy | 0 | Active |
| US10196522B2 | Method of separating oil-soluble pigment and water-soluble pigment from natural material using aerogels and an apparatus therefor | Performing Operations; Transporting | 0 | Active |
| US7378435B2 | Aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives | Human Necessities | 0 | Active |
| US7956074B2 | Aryl-isoxazolo-4-yl-oxadiazole derivatives | Chemistry; Metallurgy | 0 | Active |
| US7501422B2 | Prolinamide-tetrazole derivatives as NK3 receptor antagonists | Human Necessities | 0 | Active |
| US7399769B2 | Aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives | Human Necessities | 0 | Active |
| US7585874B2 | Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives | Human Necessities | 0 | Active |
| US7528136B2 | Prolinamide derivatives as NK3 antagonists | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.